Sustained-release delivery of octreotide from biodegradable polymeric microspheres. 2011

Yun-Seok Rhee, and MinJi Sohn, and Byung H Woo, and B C Thanoo, and Patrick P DeLuca, and Heidi M Mansour
Department of Pharmaceutical Sciences-Drug Development Division, University of Kentucky College of Pharmacy, Lexington, 40536-0596, USA.

The study reports on the drug release behavior of a potent synthetic somatostatin analogue, octreotide acetate, from biocompatible and biodegradable microspheres composed of poly-lactic-co-glycolic acid (PLGA) following a single intramuscular depot injection. The serum octreotide levels of three Oakwood Laboratories formulations and one Sandostatin LAR(®) formulation were compared. Three formulations of octreotide acetate-loaded PLGA microspheres were prepared by a solvent extraction and evaporation procedure using PLGA polymers with different molecular weights. The in vivo drug release study was conducted in male Sprague-Dawley rats. Blood samples were taken at predetermined time points for up to 70 days. Drug serum concentrations were quantified using a radioimmunoassay procedure consisting of radiolabeled octreotide. The three octreotide PLGA microsphere formulations and Sandostatin LAR(®) all showed a two-phase drug release profile (i.e., bimodal). The peak serum drug concentration of octreotide was reached in 30 min for all formulations followed by a decline after 6 h. Following this initial burst and decline, a second-release phase occurred after 3 days. This second-release phase exhibited sustained-release behavior, as the drug serum levels were discernible between days 7 and 42. Using pharmacokinetic computer simulations, it was estimated that the steady-state octreotide serum drug levels would be predicted to fall in the range of 40-130 pg/10 μL and 20-100 pg/10 μL following repeat dosing of the Oakwood formulations and Sandostatin LAR(®) every 28 days and every 42 days at a dose of 3 mg/rat, respectively.

UI MeSH Term Description Entries
D007273 Injections, Intramuscular Forceful administration into a muscle of liquid medication, nutrient, or other fluid through a hollow needle piercing the muscle and any tissue covering it. Intramuscular Injections,Injection, Intramuscular,Intramuscular Injection
D008297 Male Males
D008863 Microspheres Small uniformly-sized spherical particles, of micrometer dimensions, frequently labeled with radioisotopes or various reagents acting as tags or markers. Latex Beads,Latex Particles,Latex Spheres,Microbeads,Bead, Latex,Beads, Latex,Latex Bead,Latex Particle,Latex Sphere,Microbead,Microsphere,Particle, Latex,Particles, Latex,Sphere, Latex,Spheres, Latex
D008954 Models, Biological Theoretical representations that simulate the behavior or activity of biological processes or diseases. For disease models in living animals, DISEASE MODELS, ANIMAL is available. Biological models include the use of mathematical equations, computers, and other electronic equipment. Biological Model,Biological Models,Model, Biological,Models, Biologic,Biologic Model,Biologic Models,Model, Biologic
D011100 Polyglycolic Acid A biocompatible polymer used as a surgical suture material. Polyglycolide,Biofix,Dexon (Polyester),Dexon-S,Dexon S,DexonS
D011863 Radioimmunoassay Classic quantitative assay for detection of antigen-antibody reactions using a radioactively labeled substance (radioligand) either directly or indirectly to measure the binding of the unlabeled substance to a specific antibody or other receptor system. Non-immunogenic substances (e.g., haptens) can be measured if coupled to larger carrier proteins (e.g., bovine gamma-globulin or human serum albumin) capable of inducing antibody formation. Radioimmunoassays
D002626 Chemistry, Pharmaceutical Chemistry dealing with the composition and preparation of agents having PHARMACOLOGIC ACTIONS or diagnostic use. Medicinal Chemistry,Chemistry, Pharmaceutic,Pharmaceutic Chemistry,Pharmaceutical Chemistry,Chemistry, Medicinal
D003198 Computer Simulation Computer-based representation of physical systems and phenomena such as chemical processes. Computational Modeling,Computational Modelling,Computer Models,In silico Modeling,In silico Models,In silico Simulation,Models, Computer,Computerized Models,Computer Model,Computer Simulations,Computerized Model,In silico Model,Model, Computer,Model, Computerized,Model, In silico,Modeling, Computational,Modeling, In silico,Modelling, Computational,Simulation, Computer,Simulation, In silico,Simulations, Computer
D004337 Drug Carriers Forms to which substances are incorporated to improve the delivery and the effectiveness of drugs. Drug carriers are used in drug-delivery systems such as the controlled-release technology to prolong in vivo drug actions, decrease drug metabolism, and reduce drug toxicity. Carriers are also used in designs to increase the effectiveness of drug delivery to the target sites of pharmacological actions. Liposomes, albumin microspheres, soluble synthetic polymers, DNA complexes, protein-drug conjugates, and carrier erythrocytes among others have been employed as biodegradable drug carriers. Drug Carrier
D004339 Drug Compounding The preparation, mixing, and assembly of a drug. (From Remington, The Science and Practice of Pharmacy, 19th ed, p1814). Drug Formulation,Drug Preparation,Drug Microencapsulation,Pharmaceutical Formulation,Compounding, Drug,Formulation, Drug,Formulation, Pharmaceutical,Microencapsulation, Drug,Preparation, Drug

Related Publications

Yun-Seok Rhee, and MinJi Sohn, and Byung H Woo, and B C Thanoo, and Patrick P DeLuca, and Heidi M Mansour
August 2008, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V,
Yun-Seok Rhee, and MinJi Sohn, and Byung H Woo, and B C Thanoo, and Patrick P DeLuca, and Heidi M Mansour
August 2000, International journal of pharmaceutics,
Yun-Seok Rhee, and MinJi Sohn, and Byung H Woo, and B C Thanoo, and Patrick P DeLuca, and Heidi M Mansour
May 2006, Journal of controlled release : official journal of the Controlled Release Society,
Yun-Seok Rhee, and MinJi Sohn, and Byung H Woo, and B C Thanoo, and Patrick P DeLuca, and Heidi M Mansour
March 1992, Neurosurgery,
Yun-Seok Rhee, and MinJi Sohn, and Byung H Woo, and B C Thanoo, and Patrick P DeLuca, and Heidi M Mansour
January 1996, Journal of microencapsulation,
Yun-Seok Rhee, and MinJi Sohn, and Byung H Woo, and B C Thanoo, and Patrick P DeLuca, and Heidi M Mansour
November 2016, International journal of biological macromolecules,
Yun-Seok Rhee, and MinJi Sohn, and Byung H Woo, and B C Thanoo, and Patrick P DeLuca, and Heidi M Mansour
January 2005, Advanced drug delivery reviews,
Yun-Seok Rhee, and MinJi Sohn, and Byung H Woo, and B C Thanoo, and Patrick P DeLuca, and Heidi M Mansour
August 1993, Investigative ophthalmology & visual science,
Yun-Seok Rhee, and MinJi Sohn, and Byung H Woo, and B C Thanoo, and Patrick P DeLuca, and Heidi M Mansour
January 1997, Pharmaceutical biotechnology,
Yun-Seok Rhee, and MinJi Sohn, and Byung H Woo, and B C Thanoo, and Patrick P DeLuca, and Heidi M Mansour
October 2003, Journal of pharmaceutical sciences,
Copied contents to your clipboard!